Based on the molecular insights and mechanistic principles learned from developmental, evolutionary, and cancer biology, we recognize that the value of revisiting the K-RAS core operational principles and redesigning an alternative K-RAS targeting program are of paramount importance in pancreatic cancer [72,73]. The gene discussed is KRAS; the disease is cancer.